Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Effect of TLR2 monoclonal antibody on new blood vessels and immune rejection response after keratoplasty

Wang Ji, Yuan Jianshu, Wen Feng

Department of Ophthalmology, Ningbo Eye Hospital, Ningbo 315040, China;

For correspondence:- Wen Feng Email: fw1280@163.com

Accepted: 28 December 2018 Published: 31 January 2019

Citation: Ji W, Jianshu Y, Feng W. Effect of TLR2 monoclonal antibody on new blood vessels and immune rejection response after keratoplasty. Trop J Pharm Res 2019; 18(1):19-23 doi: 10.4314/tjpr.v18i1.3

© 2019 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the effect of TLR2 (toll-like receptor 2) monoclonal antibody on formation of new blood vessels and immune rejection response after keratoplasty.

Methods: The rats were randomly divided into negative control group consisting of 16 rats from allogeneic corneal transplantation, and TLR2 monoclonal antibody group (study group) made up of 16 rats from allogeneic corneal transplantation treated with TLR2 monoclonal antibody. A group of 8 rats served as normal control. The study group was treated with 0.5 g·L-1 TLR2 monoclonal antibody through sub-conjunctival injection once daily for 5 days, while the normal control and negative control groups were given an equivalent volume of normal saline in place of TLR2. Corneal transparency and neovascularization were observed under slit lamp daily after operation, and scored using rejection index.

Results: In the TLR2 monoclonal antibody group, the corneal structure was still clear, and only a few inflammatory cells infiltrated the stromal layer. There were trace amounts of TLR2 expression in the corneal epithelium of rats in normal control group, negative control group and TLR2 monoclonal antibody group. In the negative control group, the expression of TLR2 in the corneal epithelium and stromal cells significantly increased, especially in the stromal layer.

Conclusion: TLR2 monoclonal antibody exerts a significant effect on neovascularization and immune rejection after corneal transplantation in rats. Thus, it may be clinically suitable for the prevention and treatment of rejection arising from corneal transplantation.

Keywords: TLR2 monoclonal antibody, Corneal transplantation, Neovascularization, Immune rejection